DK25691D0 - Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat) - Google Patents

Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat)

Info

Publication number
DK25691D0
DK25691D0 DK025691A DK25691A DK25691D0 DK 25691 D0 DK25691 D0 DK 25691D0 DK 025691 A DK025691 A DK 025691A DK 25691 A DK25691 A DK 25691A DK 25691 D0 DK25691 D0 DK 25691D0
Authority
DK
Denmark
Prior art keywords
acat
cholesterol
bival
block
ligand compounds
Prior art date
Application number
DK025691A
Other languages
English (en)
Other versions
DK25691A (da
Inventor
Ronald B Gammill
Frank P Bell
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK25691D0 publication Critical patent/DK25691D0/da
Publication of DK25691A publication Critical patent/DK25691A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK025691A 1988-08-16 1991-02-14 Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat) DK25691A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23293188A 1988-08-16 1988-08-16
PCT/US1989/002572 WO1990002129A1 (en) 1988-08-16 1989-06-16 Bivalent ligands effective for blocking acat enzyme

Publications (2)

Publication Number Publication Date
DK25691D0 true DK25691D0 (da) 1991-02-14
DK25691A DK25691A (da) 1991-02-14

Family

ID=22875168

Family Applications (1)

Application Number Title Priority Date Filing Date
DK025691A DK25691A (da) 1988-08-16 1991-02-14 Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat)

Country Status (7)

Country Link
EP (1) EP0429464B1 (da)
JP (1) JPH04500506A (da)
KR (1) KR900701792A (da)
AT (1) ATE114311T1 (da)
DE (1) DE68919475T2 (da)
DK (1) DK25691A (da)
WO (1) WO1990002129A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304548A (en) * 1988-08-16 1994-04-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
US5180717A (en) * 1988-08-16 1993-01-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
WO1995027964A1 (en) * 1994-04-12 1995-10-19 Qualcomm Incorporated Method and apparatus for freight transportation using a satellite navigation system
JPWO2009038064A1 (ja) * 2007-09-19 2011-01-06 株式会社医薬分子設計研究所 I型11βヒドロキシステロイド脱水素酵素阻害活性を有する複素環誘導体
PL2268644T3 (pl) 2008-03-05 2012-01-31 Boehringer Ingelheim Int Tricykliczne pochodne piperydyny, leki zawierające te związki, ich zastosowanie i sposoby ich wytwarzania
SG183321A1 (en) 2010-02-19 2012-09-27 Boehringer Ingelheim Int Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
EP2760868B1 (en) 2011-08-17 2018-04-25 Boehringer Ingelheim International GmbH Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
CN107021940A (zh) * 2017-05-03 2017-08-08 天津国际生物医药联合研究院 一种双哌嗪类化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529561B2 (en) * 1979-02-13 1983-06-09 Upjohn Company, The Antiatherogenic 6-halofurochromones
US4412071A (en) * 1982-05-17 1983-10-25 The Upjohn Company Antiatherosclerotic compositions

Also Published As

Publication number Publication date
DE68919475T2 (de) 1995-05-11
EP0429464B1 (en) 1994-11-23
EP0429464A1 (en) 1991-06-05
ATE114311T1 (de) 1994-12-15
JPH04500506A (ja) 1992-01-30
WO1990002129A1 (en) 1990-03-08
KR900701792A (ko) 1990-12-04
AU631801B2 (en) 1992-12-10
DE68919475D1 (de) 1995-01-05
DK25691A (da) 1991-02-14
AU3835889A (en) 1990-03-23

Similar Documents

Publication Publication Date Title
NO904921D0 (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
DK246587A (da) 1-aralkylpyrazoler, fremgangsmaader til deres fremstilling og anvendelse til bekaempelse af skadelige organismer
DK641589D0 (da) N-aryl-azetidinoner, fremgangsmaade til deres fremstilling og deres anvendelse som elastaseinhibitorer
DK362787A (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK273689A (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
DK25691D0 (da) Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat)
NO875263L (no) 2,3-disubstituerte isoksazolidiner, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse.
DK435588A (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
NO165683C (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
NO884639L (no) Vannopploeselige l-tyrosinderivater og fremgangsmaate til deres fremstilling.
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
DK304090D0 (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
NO890894D0 (no) 4-substituerte pyrazolo(3,4-alfa)pyrimidinderivater og fremgangsmaate for deres fremstilling.
DK349688A (da) Bomologe af humant aprotinin, vaertsstamme samt ekspressionsvektorer til deres fremstilling og deres anvendelse som laegemidler
DK572785D0 (da) Imidazolderivater, laegemidler indeholdende disse forbindelser og fremgangsmaader til deres fremstilling
DK428485D0 (da) Aktivitetsstabiliserende enzymer, fremgangsmaade til fremstilling heraf og anvendelse af samme
NO840580L (no) Tributylfenol-etersulfonater, deres anvendelse og fremgangsmaate til fremstilling av etersulfonater
DK453184D0 (da) 1-azolyl-substituerede oximethere, fremgangsmaade til fremstilling deraf og deres anvendelse som fungicider
NO871375D0 (no) Bis-tertiaerbutylamino-substituerte 1,3,5-triazinderivater, fremgangsmaate til deres fremstilling, legemidler inneholdende disse forbindelser og deres anvendelse.
DK157187A (da) Acyloxyhiophencarboxamider, deres fremstilling og anvendelse til bekaempelse af skadelige organismer
DK120789D0 (da) 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel
NO924516D0 (no) Isoxazolylimidazolderivater, fremgangsmaater for fremstilling av disse, og deres anvendelse i legemidler
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
DK202884D0 (da) Azolylethyl-benzyl-ether-derivater,fremgangsmaade til deres fremstilling og deres anvendelse som fungicider
DK242289A (da) Diphenylsulfoner, -sulfider og -sulfoxider og deres virkning som modulatorer af immunresponssystemet